dehydroepiandrosterone has been researched along with fulvestrant in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Alexi, X; Alexis, MN; Avlonitis, N; Calogeropoulou, T; Charalampopoulos, I; Gravanis, A; Katsanou, ES; Lazaridis, I; Minas, V; Pantzou, A; Vergou, V; Zervou, M | 1 |
| Bruder, JM; Oettel, M; Sobek, L | 1 |
| Bland, KI; Chaudry, IH; Cioffi, WG; Jarrar, D; Wang, P | 1 |
| Fujita, T; Kaiho, S; Kuwabara, K; Ogata, E; Oizumi, I; Okazaki, T; Tanaka, Y | 1 |
| Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B | 1 |
| Dai, A; Dawood, T; Funder, JW; Komesaroff, PA; Lew, R; Ling, S; Myles, K; Sudhir, K; Williams, MR | 1 |
| Childs, GV; Iruthayanathan, M; Zhou, YH | 1 |
| Li, DJ; Wang, L; Wang, WJ; Wang, YD; Zhu, Y | 1 |
| Allen, JD; Arnold, JT; Blackman, MR; Le, H; Liu, X; McFann, KK | 1 |
| Hyttinen, JM; Kaarniranta, K; Kyrylenko, S; Ojala, J; Salminen, A; Suuronen, T; Thornell, A | 1 |
| Ahlem, C; Auci, D; Frincke, J; Mangano, K; Nicoletti, F; Reading, C; Stickney, D | 1 |
| Li, W; Tang, L; Wu, L; Xiong, Y; Zhou, X | 1 |
1 trial(s) available for dehydroepiandrosterone and fulvestrant
| Article | Year |
|---|---|
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.
Topics: Adult; Aged; Animals; Brachial Artery; Cattle; Cell Division; Cells, Cultured; Dehydroepiandrosterone; Double-Blind Method; Endothelial Cells; Estradiol; Female; Flutamide; Fulvestrant; Humans; Middle Aged; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Androgen; Receptors, Estrogen; Skin; Testosterone | 2004 |
12 other study(ies) available for dehydroepiandrosterone and fulvestrant
| Article | Year |
|---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dehydroepiandrosterone; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Models, Molecular; Molecular Conformation; Neurons; Neuroprotective Agents; Rats; Structure-Activity Relationship | 2009 |
Dehydroepiandrosterone stimulates the estrogen response element.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Cell Line; Dehydroepiandrosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genes, Reporter; Genetic Vectors; Humans; Luciferases; Mice; Receptors, Estrogen; Transfection | 1997 |
Mechanisms of the salutary effects of dehydroepiandrosterone after trauma-hemorrhage: direct or indirect effects on cardiac and hepatocellular functions?
Topics: Adjuvants, Immunologic; Animals; Cardiac Output; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Fulvestrant; Gonadal Steroid Hormones; Heart; Kidney; Male; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic | 2000 |
Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens.
Topics: Anastrozole; Androgens; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Dehydroepiandrosterone; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Nitriles; Triazoles; Tumor Cells, Cultured | 2000 |
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors.
Topics: Aging; Aminoglutethimide; Animals; Aromatase Inhibitors; Cells, Cultured; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Growth Hormone; Pituitary Gland; Rats; Receptors, Estrogen; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; RNA, Messenger | 2005 |
Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor.
Topics: Androgen Receptor Antagonists; Animals; Apoptosis; Bone and Bones; Bone Density Conservation Agents; Butadienes; Cell Cycle; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Flutamide; Fulvestrant; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Nitriles; Osteoblasts; Ovariectomy; Phosphorylation; Proliferating Cell Nuclear Antigen; Receptors, Androgen; Receptors, Estrogen | 2007 |
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Cell Division; Cell Line, Tumor; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Small Interfering; Testosterone; Tosyl Compounds | 2007 |
Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
Topics: Acetylation; Animals; Benzoquinones; Cell Line; Dactinomycin; Dehydroepiandrosterone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Neurons; Protein Synthesis Inhibitors; Selective Estrogen Receptor Modulators; Signal Transduction; Sirtuin 2; Sirtuins; Transcriptional Activation; Valproic Acid | 2008 |
HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease.
Topics: Administration, Oral; Androstenols; Animals; Autoimmune Diseases; Clinical Trials as Topic; Colitis, Ulcerative; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Treatment Outcome | 2009 |
The chondroprotective effects of dehydroepiandrosterone probably exerted by its conversion to estradiol.
Topics: Adjuvants, Immunologic; Animals; Aromatase Inhibitors; Cartilage; Cells, Cultured; Chondrocytes; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Letrozole; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Nitriles; Osteoarthritis; Rabbits; Tissue Inhibitor of Metalloproteinase-1; Triazoles | 2013 |